Dicot AB is a pharmaceutical company, which engages in the research, development and distribution of pharmaceuticals. The company develops a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs and is in the clinical phase. It also develops LIB-01 until clinical phase 2a and then accelerate and finance the drug development further together with pharma partners into a registered drug for the world market. The company was founded by Jarl Wikberg on March 5, 2015 and is headquartered in Uppsala, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company